Together for Better Health
Advancing therapies from concept to patient care calls for a partner who understands the complexity of your work and is committed to strengthening it.
Our teams consist entirely of qualified healthcare professionals who bring deep scientific understanding and disciplined operational excellence across pharmacovigilance, medical information, regulatory affairs, medical writing and quality assurance.
We bring scientific insight, operational strength and modern technology together. With APCER Life Sciences, you gain a partner who takes full accountability and supports your growth with precision and integrity. We are unwavering in the pursuit of our purpose of working together for better health.
Regulatory
Affairs
Clear guidance through global and local regulatory expectations. We simplify submissions, streamline compliance, and help accelerate market access.
Read More
Pharmacovigilance
End-to-end technology powered PV services that strengthen safety, ensure global compliance, and protect patients across the product lifecycle.
Read More
Medical
Information
Accurate, multilingual medical inquiry management and reporting, delivering timely, compliant responses to healthcare professionals worldwide.
Read More
Medical
Writing
Clinical, scientific and regulatory writing that is clear, compliant, and purpose-built for every stage of drug development.
Read More
Quality
Assurance
Comprehensive quality system support, inspection readiness, and training backed by integrated certifications and proven audit success.
Read MoreLet’s Build a Healthier World, Together
Driven by Science. Enhanced by Technology.
Built for Partnership.
We host Oracle ARGUS 25.1 (including Analytics and Insights) and LSMV/LSRA from ARIS. ANSA PV SafetyCore is our proprietary next generation AI powered safety database. Our ICSR services are supported by our proprietary AI powered case intake and case management tool - ANSA PV SafetyFlow, enabling fast, accurate, and secure case management at scale, that fits into your existing environment without disruption.
LEARN MORELiterature screening and review supported by our Proprietary AI Powered tool - ANSA PV LitSense, for accelerated, traceable literature screening that reduces effort while preserving full scientific oversight.
LEARN MOREOur easily customizable proprietary web application, ANSA PV REMSConnect, allows you to run complex risk management programs with complete clarity, control, and confidence, from a single platform.
LEARN MORELeveraging 3rd party technology to deliver qualitative and quantitative detection and evaluation; from multiple data sources.
LEARN MOREThe latest version of Ring Central’s cloud telephony system, and Integrated Response Management System (IRMS) medical information database (21 CFR Part 11 and GAMP 5 validated).
LEARN MOREProven Strength.
Measurable Trust
We Improve Outcomes for Everyone, Everywhere.
Real Results. Real Trust.
Real Stories
Sincerely thank you for all the effort, thoroughness and professionalism that went through conducting and reporting on this FDA PADER Gap Analysis as we now embark on our journey towards documentation and process improvement to ensure readiness for an actual inspection.
Director, Drug Safety and Medical Information
Canada-based global pharma
The APCER Pharmacovigilance team demonstrated exceptional collaboration and inspection readiness during FDA PADE Inspection. The accuracy, consistency, and completeness of expedited reports, reconciliations, and aggregate safety documentation clearly reflected strong teamwork and compliance across all deliverables.
VP, Regulatory and Quality
US-based biopharma
With all the transformation and rapid growth happening, having a reliable PV/med info partner like the APCER group has truly been invaluable—it’s made a real difference in helping us navigate the complexities and keep challenges to a minimum.
VP, Medical Affairs
US-based specialty pharma
... the preparation and support for our BPD Type 2a meeting were a strong example of APCER’s commitment and effectiveness and instrumental in keeping us aligned and confident in our regulatory strategy. We have greatly valued the team’s responsiveness, collaborative approach, and sound regulatory judgment.
Chief Medical Officer
A clinical-stage biopharma
Phase 1 completion is an achievement that demonstrates APCER's scalability, flexibility, and operational readiness. It reflects exceptional cross-functional collaboration.
Associate Director, IT Business Partner
Japan-headquartered, global healthcare company
I want to sincerely appreciate all the great work Team APCER has been doing. Their strong attention to detail, agility in handling tasks, and consistent respect for timelines have been truly impressive.
Associate Director, Safety Physician
Japan-headquartered, global healthcare company
Deep gratitude to entire APCER team for their efforts in working hard to complete the cases. While the system outage was well beyond their control, their strong work to make up for the lost time ensured that we're able to maintain compliance.
Associate Director, Pharmacovigilance Operations
US-based biotech
Sincere appreciation for APCER's partnership and dedicated service. The team’s commitment, adaptability, and collaborative approach have been instrumental in supporting our pharmacovigilance operations through both high and low volumes of activity.
Sr.Director, PV Operations-Global Case Management
US-based biotech
I’ve greatly valued APCER’s commitment to excellence. Their contributions have played a key role in helping us uphold our compliance standards and achieve strong performance across key metrics, including timely deviation closure, audit readiness, and quality of deliverables.
Sr. Director PV Ops – Pharmacovigilance Center of Excellence
US-based biotech
